Related Experiment Video

Updated: Aug 11, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Blood pressure control in type II diabetics with diabetic retinopathy

S Sivaprasad1, H Jackson

  • 1West Kent Eye Centre, Princess Royal University Hospital, Orpington, Kent, UK. senswathi@aol.com

Eye (London, England)
|February 25, 2006
PubMed

Insights

Blood pressure control is crucial for preventing blindness in diabetic retinopathy patients. However, this study found that most patients do not achieve their target blood pressure, indicating a gap in care.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Endocrinology

Background:

  • Effective blood pressure control significantly reduces the risk of blindness in patients with diabetic retinopathy.
  • Diabetic retinopathy is a leading cause of vision loss among diabetic individuals.

Purpose of the Study:

  • To audit the quality of hypertension care in type II diabetics with diabetic retinopathy.
  • To identify factors associated with suboptimal blood pressure control in this patient cohort.

Main Methods:

  • Retrospective audit of 100 consecutive type II diabetic patients with diabetic retinopathy.
  • Assessment of blood pressure control against a target of 140/80 mmHg.
  • Evaluation of patients requiring diabetic macular laser treatment.

Main Results:

  • Only 38% of patients achieved the target blood pressure of 140/80 mmHg.
  • A significant proportion (65%) of patients needing diabetic macular laser treatment had suboptimal blood pressure control.
  • Factors contributing to suboptimal blood pressure control were identified.

Conclusions:

  • Despite proven benefits, the majority of diabetic patients do not achieve goal blood pressure.
  • Suboptimal hypertension management in diabetic retinopathy patients requires attention.
  • Improved strategies are needed to optimize blood pressure control in this population.
Abstract

More Related Videos

Retinal Pathophysiological Evaluation in a Rat Model09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...